World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
16591
World Ranking
9558
National Ranking
4220

Paul A. Moore publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Paul A. Moore sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 288 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Paul A. Moore D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Paul A. Moore sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 64 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Paul A. Moore is affiliated with MacroGenics in the United States and has contributed extensively to the field of medicine, with a particular focus on oncology and immunology. Their research encompasses various aspects of cancer immunotherapy, immune response mechanisms, and therapeutic antibody development.

The scientist's recent papers highlight active involvement in advanced cancer therapies and immunological treatments. Notable publications include:

  • Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer, 2020, Molecular Cancer Therapeutics
  • Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial, 2022, Journal for ImmunoTherapy of Cancer
  • The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial, 2023, Nature Medicine
  • Nonsteroidal Anti-Inflammatory Drugs and Opioids in Postsurgical Dental Pain, 2020, Journal of Dental Research
  • Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial, 2023, Nature Medicine

Frequent co-authors collaborating with Moore include:

  • Ezio Bonvini
  • Francine Chen
  • Sandra Gabriele
  • Gundo Diedrich
  • Anushka De Costa

Moore has published regularly in several scientific venues, with the following being prominent:

  • Cancer Research
  • The Journal of the American Dental Association
  • Regular and Young Investigator Award Abstracts
  • Journal of Dental Research
  • Journal of Clinical Oncology

The scientist's work spans several subfields of medicine. These include oncology, immunology, radiology and imaging, oral surgery, and pulmonary and respiratory medicine. Their primary research topics are centered around:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Monoclonal and Polyclonal Antibodies Research
  • Dental Anxiety and Anesthesia Techniques
  • Immune Cell Function and Interaction
  • Inflammatory mediators and NSAID effects

In addition to articles, Moore has authored a book published by the University of Illinois Press titled The Sunday Paper (2022).

Best Publications

  • BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator

    Paul A. Moore;Ornella Belvedere;Amy Orr;Krystyna Pieri

  • Synthesis and release of B-lymphocyte stimulator from myeloid cells

    Bernardetta Nardelli;Ornella Belvedere;Viktor Roschke;Paul A. Moore

  • TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell Costimulator

    Thi Sau Migone;Jun Zhang;Xia Luo;Li Zhuang

  • Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK) INTERACTION WITH TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS AND ACTIVATION OF NF-κB AND c-JUN N-TERMINAL KINASE

    Bryant G. Darnay;Valsala Haridas;Jian Ni;Paul A. Moore

  • Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes.

    Wei-Chun Au;Paul A. Moore;William Lowther;Yuang-Taung Juang

  • Virus-specific Activation of a Novel Interferon Regulatory Factor, IRF-5, Results in the Induction of Distinct Interferon α Genes

    Betsy J. Barnes;Paul A. Moore;Paula M. Pitha

  • Activation of NF-κB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-κB-inducing Kinase IDENTIFICATION OF A NOVEL TRAF6 INTERACTION MOTIF

    Bryant G. Darnay;Jian Ni;Paul A. Moore;Bharat B. Aggarwal

  • Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

    Paul A. Moore;Wenjun Zhang;G. Jonah Rainey;Steve Burke

  • Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes

    David W. LaFleur;Bernardetta Nardelli;Tatiana Tsareva;Don Mather

  • Characterization of the Interferon Regulatory Factor-7 and Its Potential Role in the Transcription Activation of Interferon A Genes

    Wei-Chun Au;Paul A. Moore;David W. LaFleur;Bertrand Tombal

  • Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

    Deryk Loo;Ralph F. Alderson;Francine Z. Chen;Ling Huang

  • Regulation of Type I Interferon Gene Expression by Interferon Regulatory Factor-3

    Susan L. Schafer;Rongtuan Lin;Paul A. Moore;John Hiscott

  • CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

    L M Smith;A. I. Nesterova;M C Ryan;S Duniho

  • Effector cell recruitment with novel Fv-based dual-affinity re-targeting protein leads to potent tumor cytolysis and in vivo B-cell depletion.

    Syd Johnson;Stephen Burke;Ling Huang;Sergey Gorlatov

  • Tumor Necrosis Factor (TNF) Receptor Superfamily Member TACI Is a High Affinity Receptor for TNF Family Members APRIL and BLyS

    Youmei Wu;Dana Bressette;Jeff A. Carrell;Thomas Kaufman

  • Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties

    Jeffrey L Nordstrom;Sergey Gorlatov;Wenjun Zhang;Yinhua Yang

  • First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

    Yung-Jue Bang;G. Giaccone;S. A. Im;D. Y. Oh

  • Therapeutic Control of B Cell Activation via Recruitment of Fcγ Receptor IIb (CD32B) Inhibitory Function With a Novel Bispecific Antibody Scaffold

    Maria-Concetta Veri;Stephen Burke;Ling Huang;Hua Li

  • Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation.

    Yu-Ping Xia;Yanan Zhao;Jeffrey Marcus;Pablo A. Jimenez

  • Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform.

    Muneera Al-Hussaini;Michael P. Rettig;Julie K. Ritchey;Darja Karpova

Frequent Co-Authors

Reinhard Ebner
Reinhard Ebner Human Genome Sciences (United States)
Ezio Bonvini
Ezio Bonvini Center for Biologics Evaluation and Research
Craig A. Rosen
Craig A. Rosen CoGenesys, Inc.
Steven M. Ruben
Steven M. Ruben Celera Corporation
Jian Ni
Jian Ni Zhejiang Normal University
Syd Johnson
Syd Johnson AstraZeneca (United Kingdom)
Scott Koenig
Scott Koenig MacroGenics (United States)
Reiner L. Gentz
Reiner L. Gentz Gentz Biopharmaceutical Consulting
Paula M. Pitha
Paula M. Pitha Johns Hopkins University
Jon M. Wigginton
Jon M. Wigginton Bristol-Myers Squibb (Germany)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to diverse online degree programs and career options in healthcare, data management, and wellness. As the demand for digital health records and precision medicine grows, students might consider pursuing an online health information management degree. This path prepares graduates for roles in organizing and securing medical data within healthcare organizations.

Careers in the medical coding and billing field are also expanding. Learning about medical.coder salary can help students gauge their earning potential, while investigating is medical billing and coding in demand offers insights into job stability and growth prospects in this essential healthcare support sector.

For those passionate about nutrition and its role in health, multiple online degrees in nutrition are available. Such programs can prepare graduates for careers in clinical nutrition, dietetics, or wellness consulting. With flexible online options, students can tailor their studies to fit their career goals in a rapidly evolving healthcare landscape.

Best Scientists Citing Paul A. Moore

Trending Scientists

Recently Published Articles